Archive for July 31st, 2010
– Lundbeck Inc. has voluntarily recalled two lots of NeoProfen® (ibuprofen lysine) Injection that failed to meet a visible particulate quality requirement. These two lots are the only lots currently available to prescribers and therefore the recall will result in a temporary drug shortage.
Tags: FDA Recalls
– Lundbeck Inc. has voluntarily recalled two lots of NeoProfen® (ibuprofen lysine) Injection that failed to meet a visible particulate quality requirement. These two lots are the only lots currently available to prescribers and therefore the recall will result in a temporary drug shortage. This voluntary recall is the result of the company’s inspections of the two product lots of NeoProfen.
Tags: FDA Recalls
Increased incidence of fever and febrile seizure among young children reported in Australia, mainly among those less than 5 years of age.
Tags: MedWatch Safety Alerts